Becton, Dickinson and Company (BDX)
Becton, Dickinson and Company (BDX) Q1 2026 Earnings Call Transcript
Becton, Dickinson and Company (BDX) Q1 2026 Earnings Call Transcript
BD Stock Dips in Pre-Market Despite Q1 Earnings Beat, Margins Up
BDX posts an earnings beat with revenue growth and expanding margins in first-quarter fiscal 2026 quarter, though adjusted profit declined year over year.
Becton Dickinson (BDX) Beats Q1 Earnings and Revenue Estimates
Becton Dickinson (BDX) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.82 per share. This compares to earnings of $3.43 per share a year ago.
Countdown to Becton Dickinson (BDX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
BD & Envetec Showcase Closed-Loop Recycling Solution for Lab Plastics
BDX completes a pilot with Envetec showing polystyrene Petri dishes can be safely recycled into new medical-grade feedstock.
Earnings Preview: Becton Dickinson (BDX) Q1 Earnings Expected to Decline
Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry
BD launches BD Research Cloud 7.0 with AI-powered Horizon Panel Maker, boosting automation, data intelligence and productivity in flow cytometry.
BDX vs. SAUHY: Which Stock Is the Better Value Option?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Straumann Holding AG (SAUHY). But which of these two stocks offers value investors a better bang for their buck right now?
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BD and Ypsomed Expand Partnership to Target Growing Biologics Market
BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System
BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.
